Report Scope:
This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tool markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Report Includes:

  • 109 tables
  • An updated review of the global market for exosome diagnostics and therapeutics within the biotech research industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation and forecast the overall global market size, and corresponding market share analysis by application, end-user, and geographic region
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Evaluation of exosome proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Impact of exosome research on specific biopharmaceutical market and summary of details for major companies researching and producing exosome products
  • A relevant patent analysis on Exosome Diagnostics and Therapeutics in the U.S., Europe and Japan
  • Competitive landscape of the major players operating within global market, and their global rankings and company share analysis
  • Profile descriptions of the leading vendor companies including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics Inc., NonoSomiX Inc., and System Biosciences,